Endari Is a Proven Safe and Effective Sickle Cell Treatment

Product developed at LA BioMed is a safe, economical, available primary therapy

Last night’s episode of CBS’ “60 Minutes” brought much-needed awareness of the hardships faced by the estimated 25 million people around the world living with sickle cell disease. The broadcast highlighted an experimental gene therapy-based treatment that might someday even cure the disease. However, at this time, it is not available to the general public and remains in an experimental stage where potential complications and consistent efficacy are still being evaluated. Also, the procedure is potentially hugely expensive should it ever be commercialized.

The Los Angeles Biomedical Research Institute (LA BioMed) and BioLabs Launch Los Angeles Location

Innovation Center for Life Science Startups Slated for Spring 2019 Opening

Southern California Philanthropists Richard and Melanie Lundquist Make $70 Million Unrestricted Gift to LA BioMed, Will Be Renamed Lundquist Institute

Funds will go toward recruiting top researchers and improving facilities in the South Bay region of LA County – one of the nation’s top ten biotech clusters

LA BioMed Launches Unique Doctoral Program in Translational Research

New Program Creates a Triple Threat: Graduates with Clinical, Business & Research Skills

New Program Creates a Triple Threat: Graduates with Clinical, Business & Research Skills

First Trial Launches to Test Effectiveness of Male Contraceptive Gel

Clinical sites seek couples to enroll in year-long study of pregnancy prevention

Pay Inequality Hits the Operating Room – LA BioMed Study Finds Female Docs Uncomfortable Pursuing Comparable Salaries to Men

While male and female surgeons both work equally hard saving lives in the operating room, women in general surgery project earning significantly less than men. This disparity is due to women underestimating their future earning power, and to differing approaches to salary negotiation, according to an important new study from LA BioMed, an independent non-profit biomedical research organization.

LA BioMed Launches Groundbreaking Study on Deadly Skin Infections

$5.3 million NIH grant will fund research on effective therapies for antibiotic-resistant strains

LA BioMed Leads Groundbreaking Studies on Deadly Infectious Disease

Two studies are part of broader effort to take aim at one of the world’s deadliest infections

LA BioMed At Center of LA County Bioscience Summit

Dr. Meyer to lead panel of thought leaders capitalizing on region’s role as influential bioscience hub

Disruptions and Future Trends Shaping Bio-Tech Industry Investments Reveal Los Angeles as New Node

Event Bolsters Los Angeles as a National Biotech Hub